2-74490080-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022492.6(TTC31):c.185G>A(p.Arg62Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000021 in 1,526,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022492.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTC31 | NM_022492.6 | c.185G>A | p.Arg62Gln | missense_variant | 3/13 | ENST00000233623.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTC31 | ENST00000233623.11 | c.185G>A | p.Arg62Gln | missense_variant | 3/13 | 1 | NM_022492.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000335 AC: 5AN: 149436Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000294 AC: 6AN: 204354Hom.: 0 AF XY: 0.0000363 AC XY: 4AN XY: 110042
GnomAD4 exome AF: 0.0000196 AC: 27AN: 1377130Hom.: 0 Cov.: 35 AF XY: 0.0000249 AC XY: 17AN XY: 682790
GnomAD4 genome AF: 0.0000335 AC: 5AN: 149436Hom.: 0 Cov.: 32 AF XY: 0.0000137 AC XY: 1AN XY: 72968
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 04, 2024 | The c.185G>A (p.R62Q) alteration is located in exon 3 (coding exon 3) of the TTC31 gene. This alteration results from a G to A substitution at nucleotide position 185, causing the arginine (R) at amino acid position 62 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at